The preparation method of bazedoxifene acetate polymorph a
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SUZHOU LIXIN PHARMA
- Publication Date
- 2021-03-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of preparation of raw materials and intermediates, and in particular relates to a preparation method of polymorphic form A of bazedoxifene acetate, a new generation of selective estrogen receptor modulator. Background technique
[0002] Bazedoxifene Acetate is a small molecule drug originally developed by Wyeth and later acquired by Pfizer. Bazedoxifene acetate was first launched in Italy and Spain with the approval of the European Medicines and Drug Administration (EMEA) in April 2009, with the product name Conbriza; in July 2010, it was launched in Japan with the product name Viviant; in October 2013, it was launched in the United States. Approved by the Food and Drug Administration (FDA), it is marketed in the United States under the trade name Duavee for the treatment of moderate to severe menopause-related vasomotor symptoms (hot flashes) and the prevention of postmenopausal osteoporosis in postmenopaus...